Search

everythinglearnresearchcommunity

for

Search:↓

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Hair loss link to severe COVID-19 unclear.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

No clear link between androgenetic alopecia and COVID-19 was found.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

A boy with a rare skin condition improved quickly after starting zinc supplements.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Diet and nutrients, including lycopene from tomatoes and hydroquinone from wheat, can help control melasma, a skin condition.